34 results
S-3ASR
EX-1.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
will assume an advisory or fiduciary responsibility in favor of the Company with respect to the transactions contemplated hereby or the process leading
S-3ASR
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
with a specific offering. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you … no responsibility for any other information that others may give you. You should not assume that the information in this prospectus is accurate as of any date other
S-3ASR
EX-4.3
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.
“United States” means … requirements hereof.
Neither the Trustee nor any Agent shall have any responsibility for any actions taken or not taken by the Depositary.
ARTICLE THREE
S-8
EX-99.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Registration of securities for employees
4:05pm
that the ultimate liability for all taxes legally due by the Participant is and remains the Participant’s responsibility. The Participant further acknowledges
DEFA14A
ne6brhh 00p
28 May 24
Additional proxy soliciting materials
7:36am
8-K
EX-99.1
uenp jop15y3r0hl6l5
28 May 24
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
7:35am
8-K
1kah0jqeysisaqzat
28 May 24
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
7:35am
DEF 14A
407fl26w58m9 u2aq14v
24 Apr 24
Definitive proxy
4:15pm
424B4
2h9tkkdtro dk
11 Mar 24
Prospectus supplement with pricing info
6:01am
10-K
EX-10.6
w3zwbek4s6pp7 lyx
5 Mar 24
Annual report
6:15am
10-K
EX-97.1
uwzjfe nw
5 Mar 24
Annual report
6:15am
10-K
f6z91blr bu5snpdqiwg
5 Mar 24
Annual report
6:15am
DRS
qb8o0qjmxlg2769mj3
9 Feb 24
Draft registration statement
12:00am
10-Q
qxal4b7
28 Aug 23
Quarterly report
8:00am